Nature Communications (Dec 2019)

Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway

  • Sisi Chen,
  • Qiang Wang,
  • Hao Yu,
  • Maegan L. Capitano,
  • Sasidhar Vemula,
  • Sarah C. Nabinger,
  • Rui Gao,
  • Chonghua Yao,
  • Michihiro Kobayashi,
  • Zhuangzhuang Geng,
  • Aidan Fahey,
  • Danielle Henley,
  • Stephen Z. Liu,
  • Sergio Barajas,
  • Wenjie Cai,
  • Eric R. Wolf,
  • Baskar Ramdas,
  • Zhigang Cai,
  • Hongyu Gao,
  • Na Luo,
  • Yang Sun,
  • Terrence N. Wong,
  • Daniel C. Link,
  • Yunlong Liu,
  • H. Scott Boswell,
  • Lindsey D. Mayo,
  • Gang Huang,
  • Reuben Kapur,
  • Mervin C. Yoder,
  • Hal E. Broxmeyer,
  • Zhonghua Gao,
  • Yan Liu

DOI
https://doi.org/10.1038/s41467-019-13542-2
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 14

Abstract

Read online

Ageing is associated with clonal hematopoiesis of indeterminate potential (CHIP), which is linked to increased risks of hematological malignancies. Here the authors uncover an epigenetic mechanism through which mutant p53 drives clonal hematopoiesis through interaction with EZH2.